Biotest AG
F:BIO3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biotest AG
F:BIO3
|
DE |
|
F
|
First Commonwealth Financial Corp
F:FCF
|
US |
|
A
|
ASML Holding NV
XBER:ASME
|
NL |
|
Alstom SA
PAR:ALO
|
FR |
|
4
|
4C Group AB
F:K0E
|
SE |
|
Ai-Media Technologies Ltd
ASX:AIM
|
AU |
|
Tod's SpA
F:TOB
|
IT |
|
I
|
InPlay Oil Corp
F:8DA1
|
CA |
|
C
|
Cascadia Minerals Ltd
XTSX:CAM
|
US |
|
Metropolitan Bank Holding Corp
NYSE:MCB
|
US |
|
clearvise AG
XETRA:ABO
|
DE |
|
First Commonwealth Financial Corp
NYSE:FCF
|
US |
|
A
|
Avance Gas Holding Ltd
XBER:A07
|
BM |
|
Aperam SA
AEX:APAM
|
LU |
|
C
|
Cincinnati Financial Corp
F:CCJ
|
US |
|
E
|
Espey MFG and Electronics Corp
AMEX:ESP
|
US |
|
Marex Group PLC
F:8UU
|
UK |
|
Teleperformance SE
OTC:TLPFF
|
FR |
|
dentalcorp Holdings Ltd
OTC:DNTCF
|
CA |
|
G
|
Genfit SA
F:XUPB
|
FR |
|
C
|
Chipotle Mexican Grill Inc
F:C9F
|
US |
|
Global Ship Lease Inc
NYSE:GSL
|
UK |
Bankruptcy Probability
Biotest AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biotest AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Biotest AG
XETRA:BIO
|
795.6m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biotest AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biotest AG has total debt of 639.8m EUR. This includes both short-term (0 EUR) and long-term (639.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
